The insider selling is too small to warrant a trading response. Monitor for any upcoming clinical data readouts or financing events that could drive the stock; this cluster provides no directional edge.
Price Chart
Executive Summary
Two directors at Acumen Pharmaceuticals sold a combined $29K in open-market shares over a 7-day window, representing ~0.02% of the $165M market cap. The sales are trivial in size and involve no C-suite executives, consistent with routine option exercise-and-sell activity. No material signal for the stock.
Key Financial Metrics
Key Facts
- Two directors (Porter Derrell and Fountain Nathan B) sold shares in open-market transactions.
- Total open-market sales: $29K (0.02% of $165M market cap).
- Porter Derrell's sales were accompanied by derivative exercises at $0 and $1.07, indicating option exercise-and-sell pattern.
- No C-suite officers (CEO, CFO, etc.) participated in the cluster.
- Recent 30-day insider activity shows $90K in total sales, still immaterial relative to market cap.
Financial Impact
Total insider sales of $29K represent negligible economic impact on the company's $165M market capitalization.
Risk Factors
- Insider selling could accelerate if negative clinical or regulatory news emerges, but current activity is routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ABOS-1781730657420 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.07 | awaiting T+20 | — | $2.16 (+4.40%) |
Oct 26, 2026 today | Press Release | $2.05 | awaiting T+20 | — | $2.16 (+5.37%) |
Oct 22, 2026 4d ago | Press Release | $2.06 | awaiting T+20 | — | $2.16 (+4.85%) |
Oct 19, 2026 6d ago | Press Release | $2.02 | awaiting T+20 | — | $2.16 (+7.20%) |
Sep 16, 2026 5w ago | 8-K | $2.61 $1.82 | ▼ −30.46% | ▼ −33.64% | $2.16 (−17.24%) |
Aug 12, 2026 10w ago | Institutional Cluster | $2.51 $2.86 | ▲ +13.94% | ▲ +15.84% | $2.16 (−13.94%) |
Aug 12, 2026 10w ago | 8-K | $2.51 $2.86 | ▲ +13.94% | ▲ +15.84% | $2.16 (−13.94%) |
Aug 12, 2026 10w ago | Press Release | $2.51 $2.86 | ▼ −13.94% | ▼ −15.84% | $2.16 (+13.94%) |
Jun 17, 2026 18w ago | Insider Cluster | $2.26 $2.17 | ▼ −3.98% | ▼ −4.52% | $2.16 (−4.42%) |
Jun 16, 2026 18w ago | 8-K | $2.29 $2.53 | ▲ +10.48% | ▲ +10.28% | $2.16 (−5.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers